DE602004018014D1 - Cxcl8-antagonisten - Google Patents

Cxcl8-antagonisten

Info

Publication number
DE602004018014D1
DE602004018014D1 DE602004018014T DE602004018014T DE602004018014D1 DE 602004018014 D1 DE602004018014 D1 DE 602004018014D1 DE 602004018014 T DE602004018014 T DE 602004018014T DE 602004018014 T DE602004018014 T DE 602004018014T DE 602004018014 D1 DE602004018014 D1 DE 602004018014D1
Authority
DE
Germany
Prior art keywords
cxcl8
antagonists
interleukin
vivo
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004018014T
Other languages
English (en)
Inventor
Amanda Proudfoot
Jeffrey Shaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SA
Serono Laboratories UK Ltd
Original Assignee
Laboratoires Serono SA
Serono Laboratories UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Serono SA, Serono Laboratories UK Ltd filed Critical Laboratoires Serono SA
Publication of DE602004018014D1 publication Critical patent/DE602004018014D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/5421IL-8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE602004018014T 2003-10-22 2004-10-22 Cxcl8-antagonisten Expired - Fee Related DE602004018014D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03103909 2003-10-22
PCT/EP2004/052637 WO2005040210A2 (en) 2003-10-22 2004-10-22 Novel cxcl8 antagonists

Publications (1)

Publication Number Publication Date
DE602004018014D1 true DE602004018014D1 (de) 2009-01-08

Family

ID=34486342

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004018014T Expired - Fee Related DE602004018014D1 (de) 2003-10-22 2004-10-22 Cxcl8-antagonisten

Country Status (10)

Country Link
US (1) US20090022657A1 (de)
EP (1) EP1673388B1 (de)
JP (1) JP2007533300A (de)
AT (1) ATE415420T1 (de)
AU (1) AU2004283910A1 (de)
CA (1) CA2534828A1 (de)
DE (1) DE602004018014D1 (de)
IL (1) IL175019A0 (de)
NO (1) NO20062316L (de)
WO (1) WO2005040210A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3089489C (en) * 2018-01-18 2025-02-04 Third Wave Bioactives, Llc FRUIT AND VEGETABLE-BASED FERMENTED PRODUCT COMPOSITIONS, AND METHODS FOR PREPARING AND USING THESE
TR201811689A2 (tr) * 2018-08-10 2018-09-21 Hacettepe Ueniversitesi Cxcl8 ami̇no ucu öncül di̇zi̇si̇nden türevlenen i̇mmünmodülatör pepti̇t

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3078892A (en) * 1991-12-04 1993-06-28 Biomedical Research Centre Limited, The Human interleukin-8 analogs
AU3681795A (en) * 1994-09-23 1996-04-09 University Of Nebraska Board Of Regents Polypeptide agonists and antagonists of human interleukin-8
UA77950C2 (en) * 2000-10-04 2007-02-15 Applied Research Systems Use of mutants of cc chemokines for treatment of multiple sclerosis

Also Published As

Publication number Publication date
EP1673388B1 (de) 2008-11-26
WO2005040210A2 (en) 2005-05-06
JP2007533300A (ja) 2007-11-22
AU2004283910A1 (en) 2005-05-06
CA2534828A1 (en) 2005-05-06
ATE415420T1 (de) 2008-12-15
IL175019A0 (en) 2006-08-20
EP1673388A2 (de) 2006-06-28
US20090022657A1 (en) 2009-01-22
NO20062316L (no) 2006-06-23
WO2005040210A3 (en) 2005-06-23

Similar Documents

Publication Publication Date Title
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
ATE451376T1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
TW200604168A (en) Azaindoles useful as inhibitors of rock and other protein kinases
EA200602062A1 (ru) Амидосоединения и их применение в качестве фармацевтических средств
ATE466580T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE468336T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE365733T1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
BG66084B1 (bg) Циклопентаноиндоли, състави,съдържащи такива съединения и използването им
EA200500169A1 (ru) Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение
ATE548363T1 (de) 3,5-disubstituierte pyrid-2-one, die sich als inhibitoren der tec-familie von nicht-rezeptor- tyrosinkinasen eignen
ATE446313T1 (de) Muteine von tränen-lipocalin
DE602006004844D1 (de) Pyrrolopyrimidine verwendbar als protein kinase inhibitoren
EA200701036A1 (ru) Лактамные соединения и их применение в качестве фармацевтических препаратов
EA200602243A1 (ru) 3-аминоциклопентанкарбоксамиды в качестве модуляторов хемокиновых рецепторов
ATE450530T1 (de) Zusammensetzungen zur verwendung als protein- kinase-inhibitoren
MXPA06011327A (es) Azaindoles utiles como inhibidores de jak y otras proteinas cinasas.
EP1796669A4 (de) Aminopiperidine als dipeptidylpeptidase-iv-inhibitoren zur behandlung oder prävention von diabetes
GEP20074078B (en) Fluoro substituted cyclo-alkanoindoles, compositions comprising them and their use
MXPA05005223A (es) Diaminotriazoles utiles como inhibidores de proteinas cinasas.
DOP2002000438A (es) Inhibidores de la dipetidil peptidasa beta-amino heterocíclica para el tratamiento o la prevención de la diabetes
MX2007003013A (es) Amidas biciclicas como inhibidores de cinasa.
TW200800976A (en) New compounds for the treatment of neurological, psychiatric or pain disorders
TW200608966A (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
ATE389651T1 (de) Als inhibitoren von c-met geeignete pyrrolzusammensetzungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee